Click here to close
Hello! We notice that you are using Internet Explorer, which is not supported by Xenbase and may cause the site to display incorrectly.
We suggest using a current version of Chrome,
FireFox, or Safari.
Regulation of the stability of poly(I)xpoly(C)-induced human fibroblast interferon mRNA: selective inactivation of interferon mRNA and lack of involvement of 2',5'-oligo(A) synthetase activation during the shutoff of interferon production.
Sehgal PB
,
Gupta SL
.
???displayArticle.abstract???
The inactivation of interferon mRNA during the shutoff phase of interferon production in poly(I)xpoly(C)-induced human fibroblast cultures is selective. We have determined that the shutoff of interferon production, which takes place from 3 to 8 hr after the beginning of induction, is not associated with an appreciable declined in the rate of bulk cellular protein synthesis or of cellular protein secretion. While the amount of translatable interferon mRNA declined markedly during the shutoff phase, the level of translatable bulk cellular mRNA and the stability of [3H]uridine-labeled mRNA were unaffected. Superinduction with actinomycin D selectively stabilized interferon mRNA with no apparent effect on the stability of bulk cellular mRNA. Furthermore, an activation of the 2',5'-oligo(A) synthetase/endonuclease system does not appear to be involved in the shutoff phenomenon. Uninduced FS-4 cells contained a low basal level of 2'5'-oligo(A) synthetase activity, which was unchanged in poly(I)xpoly(C)-induced cells during the shutoff phase. Treatment of FS-4 cells with interferon for 16-18 hr prior to induction increased the enzyme activity by approximately 200-fold. However, this did not inhibit interferon production after induction with poly(I)xpoly(C) alone or after superinduction with cycloheximide or actinomycin D or both. Furthermore, the rates of decay of interferon production were comparable in cells with either a basal or an increased level of 2',5'-oligo(A) synthetase. Thus a 200-fold increase in 2',5'-oligo(A) synthetase level did not affect either the stability of interferon mRNA or the efficacy of interferon superinduction by metabolic inhibitors.
Armstrong,
Semi-micro, dye-binding assay for rabbit interferon.
1971, Pubmed
Armstrong,
Semi-micro, dye-binding assay for rabbit interferon.
1971,
Pubmed
Baglioni,
Interferon action may be mediated by activation of a nuclease by pppA2'p5'A2'p5'A.
1978,
Pubmed
Cavalieri,
Induction and decay of human fibroblast interferon mRNA.
1977,
Pubmed
,
Xenbase
Cereghini,
Studies on the efficiency of translation and on the stability of actin messenger ribonucleic acid in mouse sarcoma ascites cells.
1979,
Pubmed
Chatterjee,
Superinduction of alpha 2u globulin by actinomycin D: evidence for drug-mediated increase in alpha 2u mRNA.
1979,
Pubmed
Clemens,
Inhibition of cell-free protein synthesis by pppA2'p5'A2'p5'A: a novel oligonucleotide synthesized by interferon-treated L cell extracts.
1978,
Pubmed
Enger,
Thionein gene expression in Cd++-variants of the CHO cell: correlation of thionein synthesis rates with translatable mRNA levels during induction, deinduction, and superinduction.
1979,
Pubmed
GARREN,
A PARADOXICAL EFFECT OF ACTINOMYCIN D: THE MECHANISM OF REGULATION OF ENZYME SYNTHESIS BY HYDROCORTISONE.
1964,
Pubmed
Guyette,
Prolactin-mediated transcriptional and post-transcriptional control of casein gene expression.
1979,
Pubmed
Havell,
Production of high-titered interferon in cultures of human diploid cells.
1972,
Pubmed
Hovanessian,
Increased nuclease activity in cells treated with pppA2'p5'A2'p5' A.
1979,
Pubmed
Kerr,
Nature of inhibitor of cell-free protein synthesis formed in response to interferon and double-stranded RNA.
1977,
Pubmed
Kerr,
pppA2'p5'A2'p5'A: an inhibitor of protein synthesis synthesized with an enzyme fraction from interferon-treated cells.
1978,
Pubmed
Lowenhaupt,
Synthesis and turnover of globin mRNA in murine erythroleukemia cells induced with hemin.
1979,
Pubmed
MCAUSLAN,
THE INDUCTION AND REPRESSION OF THYMIDINE KINASE IN THE POXVIRUS-INFECTED HELA CELL.
1963,
Pubmed
Nilsen,
Mechanism for discrimination between viral and host mRNA in interferon-treated cells.
1979,
Pubmed
Ratner,
Interferon, double-stranded RNA and RNA degradation. Fractionation of the endonucleaseINT system into two macromolecular components; role of a small molecule in nuclease activation.
1978,
Pubmed
Sehgal,
Enhancement of human interferon production by neutral red and chloroquine: analysis of inhibition of protein degradation and macromolecular synthesis.
1975,
Pubmed
Sehgal,
Superinduction of human fibroblast interferon production: further evidence for increased stability of interferon mRNA.
1978,
Pubmed
Sehgal,
Halogenated benzimidazole ribosides, Novel inhibitors of RNA synthesis.
1978,
Pubmed
Sehgal,
Human interferon production: superinduction by 5,6-dichloro-1-beta-D-ribofuranosylbenzimidazole.
1975,
Pubmed
Sehgal,
Two mechanisms contribute to the superinduction of poly(I).poly(C)-induced human fibroblast interferon production.
1979,
Pubmed
Sehgal,
An evaluation of messenger RNA competition in the shutoff of human interferon production.
1976,
Pubmed
Sehgal,
Regulation of human interferon production. I. Superinduction by 5, 6-dichloro-1-beta-D-ribofuranosylbenzimidazole.
1976,
Pubmed
Sehgal,
Interferon messenger RNA content of human fibroblasts during induction, shutoff, and superinduction of interferon production.
1977,
Pubmed
,
Xenbase
Stark,
2-5A synthetase: assay, distribution and variation with growth or hormone status.
1979,
Pubmed
Tan,
Regulation of cellular interferon production: enhancement by antimetabolites.
1970,
Pubmed
Tan,
Human chromosome 21 dosage: effect on the expression of the interferon induced antiviral state.
1974,
Pubmed
Tomkins,
Further evidence for posttranscriptional control of inducible tyrosine aminotransferase synthesis in cultured hepatoma cells.
1972,
Pubmed
Vilcek,
Differential effects of actinomycin D and puromycin on the release of interferon induced by double stranded RNA.
1969,
Pubmed
Vilcek,
Stabilization of interferon messenger RNA activity by treatment of cells with metabolic inhibitors and lowering of the incubation temperature.
1973,
Pubmed
Williams,
Inhibition of protein synthesis by 2'-5' linked adenine oligonucleotides in intact cells.
1978,
Pubmed
